CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Total	Cumulative effect of adjustments	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative effect of adjustments	Accumulated other comprehensive loss	Accumulated deficit	Accumulated deficit Cumulative effect of adjustments
Beginning balance, shares at Jun. 30, 2021			94,504,000
Beginning balance at Jun. 30, 2021	$ 2,529,590,000	$ (216,066,000)	$ 2,000	$ 2,777,155,000	$ (245,066,000)	$ (100,000)	$ (247,467,000)	$ 29,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon public offering, net of underwriting discounts and other offering costs (in shares)			5,074,000
Issuance of common stock upon public offering, net of underwriting discounts and other offering costs	1,341,122,000			1,341,122,000
Issuance of common stock as consideration for an acquisition, net of issuance costs (in shares)			1,788,000
Issuance of common stock as consideration for the acquisition, net of issuance costs	488,263,000			488,263,000
Fair value of replacement awards	26,710,000			26,710,000
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			3,283,000
Issuance of common stock upon exercise of stock options and release of restricted stock units	34,024,000			34,024,000
Issuance of common stock under the employee stock purchase plan (in shares)			82,000
Issuance of common stock under the employee stock purchase plan	12,849,000			12,849,000
Purchase of capped calls	(37,893,000)			(37,893,000)
Stock-based compensation	201,573,000			201,573,000
Other comprehensive income (loss)	(10,117,000)					(10,117,000)
Net loss	(326,361,000)						(326,361,000)
Ending balance, shares at Jun. 30, 2022			104,731,000
Ending balance at Jun. 30, 2022	4,043,694,000		$ 2,000	4,598,737,000		(10,217,000)	(544,828,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock as consideration for an acquisition, net of issuance costs (in shares)			40,000
Issuance of common stock as consideration for the acquisition, net of issuance costs	3,375,000			3,375,000
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			2,703,000
Issuance of common stock upon exercise of stock options and release of restricted stock units	13,872,000			13,872,000
Issuance of common stock under the employee stock purchase plan (in shares)			182,000
Issuance of common stock under the employee stock purchase plan	$ 17,879,000			17,879,000
Repurchase and retirement of common stock (in shares)	(1,077,445)		(1,106,000)
Repurchase and retirement of common stock	$ (87,615,000)						(87,615,000)
Stock-based compensation	312,760,000			312,760,000
Other comprehensive income (loss)	5,729,000					5,729,000
Net loss	$ (223,725,000)						(223,725,000)
Ending balance, shares at Jun. 30, 2023	106,550,000		106,550,000
Ending balance at Jun. 30, 2023	$ 4,085,969,000		$ 2,000	4,946,623,000		(4,488,000)	(856,168,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			2,754,000
Issuance of common stock upon exercise of stock options and release of restricted stock units	13,002,000			13,002,000
Issuance of common stock under the employee stock purchase plan (in shares)			225,000
Issuance of common stock under the employee stock purchase plan	$ 16,495,000			16,495,000
Repurchase and retirement of common stock (in shares)	(2,882,634)		(2,883,000)
Repurchase and retirement of common stock	$ (211,902,000)						(211,902,000)
Unwind of capped calls	9,657,000			9,657,000
Stock-based compensation	247,260,000			247,260,000
Other comprehensive income (loss)	2,598,000					2,598,000
Net loss	$ (28,878,000)						(28,878,000)
Ending balance, shares at Jun. 30, 2024	106,646,000		106,646,000
Ending balance at Jun. 30, 2024	$ 4,134,201,000		$ 2,000	$ 5,233,037,000		$ (1,890,000)	$ (1,096,948,000)